Buckingham Capital Management (Ohio)’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$12.9M Buy
197,505
+2,501
+1% +$164K 1.48% 21
2024
Q3
$15.2M Sell
195,004
-10,133
-5% -$789K 1.74% 15
2024
Q2
$16M Sell
205,137
-3,085
-1% -$241K 1.91% 15
2024
Q1
$14.1M Buy
208,222
+6,709
+3% +$455K 1.73% 16
2023
Q4
$13.6M Buy
201,513
+1,906
+1% +$128K 1.82% 15
2023
Q3
$13.5M Buy
199,607
+3,312
+2% +$224K 2.06% 14
2023
Q2
$14M Sell
196,295
-5,232
-3% -$374K 2.09% 14
2023
Q1
$14M Buy
201,527
+2,728
+1% +$189K 2.24% 11
2022
Q4
$13.5M Buy
198,799
+2,213
+1% +$150K 2.35% 10
2022
Q3
$10.8M Buy
196,586
+6,467
+3% +$355K 2.09% 14
2022
Q2
$12.6M Sell
190,119
-4,656
-2% -$308K 2.35% 12
2022
Q1
$12.9M Buy
194,775
+2,131
+1% +$141K 2.12% 14
2021
Q4
$11.2M Buy
192,644
+4,106
+2% +$239K 1.74% 20
2021
Q3
$11.3M Buy
188,538
+5,764
+3% +$346K 1.85% 18
2021
Q2
$10.9M Buy
182,774
+4,723
+3% +$283K 1.77% 20
2021
Q1
$8.85M Buy
178,051
+1,942
+1% +$96.6K 1.49% 24
2020
Q4
$8.8M Buy
176,109
+3,530
+2% +$176K 1.55% 24
2020
Q3
$9.46M Buy
172,579
+7,849
+5% +$430K 1.88% 16
2020
Q2
$8.71M Buy
164,730
+19,201
+13% +$1.02M 1.9% 15
2020
Q1
$6.5M Sell
145,529
-18,417
-11% -$822K 1.63% 17
2019
Q4
$8.17M Buy
163,946
+20,361
+14% +$1.02M 1.42% 19
2019
Q3
$6.4M Buy
143,585
+38,852
+37% +$1.73M 1.19% 24
2019
Q2
$4.32M Buy
104,733
+46,638
+80% +$1.93M 0.82% 38
2019
Q1
$2.35M Buy
58,095
+30,843
+113% +$1.25M 0.46% 58
2018
Q4
$1.04M Sell
27,252
-25
-0.1% -$949 0.23% 87
2018
Q3
$1.08M Buy
27,277
+315
+1% +$12.5K 0.21% 94
2018
Q2
$947K Buy
26,962
+1,144
+4% +$40.2K 0.19% 98
2018
Q1
$903K Buy
25,818
+531
+2% +$18.6K 0.19% 102
2017
Q4
$877K Buy
25,287
+1,056
+4% +$36.6K 0.18% 106
2017
Q3
$821K Buy
24,231
+1,003
+4% +$34K 0.18% 107
2017
Q2
$792K Buy
+23,228
New +$792K 0.18% 108
2014
Q2
Sell
-15,588
Closed -$506K 174
2014
Q1
$506K Buy
15,588
+572
+4% +$18.6K 0.17% 131
2013
Q4
$446K Buy
15,016
+260
+2% +$7.72K 0.16% 136
2013
Q3
$382K Buy
14,756
+886
+6% +$22.9K 0.16% 137
2013
Q2
$328K Buy
+13,870
New +$328K 0.13% 137